Theodore Witek

Theodore J.
Witek is currently Chairman at Molecular Science Corp., Director at Trudell Medical Ltd. since 2014, Independent Non-Executive Director at AFT Pharmaceuticals Ltd. since 2020, Director at Ontario Health Innovation Council, Special Advisor at Lumira Capital Investment Management, Inc., and Professor at both Dalla Lana School of Public Health and Leslie Dan Faculty of Pharmacy.
Former roles include President & Chief Executive Officer at Boehringer Ingelheim Ltda.
from 1992 to 2008, President & Chief Executive Officer at Boehringer Ingelheim (Canada) Ltd. from 1992 to 2014, Chairman at American Thoracic Society, Inc. from 2010 to 2012, Chairman at Ehave, Inc., Independent Director at Helix BioPharma Corp., Director at Innovative Medicines Canada, and Senior Vice President-Clinical & Medical Affairs at Innoviva, Inc. from 2014 to 2018.
Education includes a doctorate from The Trustees of Columbia University in The City of New York, graduate studies at Yale University, and an MBA from Henley Management College.